Cancer-Mutated Ribosome Protein L22 (RPL22/eL22) Suppresses Cancer Cell Survival by Blocking P53-Mdm2 Circuit
Oncotarget - United States
doi 10.18632/oncotarget.21544
Full Text
Open PDFAbstract
Available in full text
Categories
Date
October 6, 2017
Authors
Publisher
Impact Journals, LLC